2023 Q4 Form 10-Q Financial Statement

#000149315223045617 Filed on December 20, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 2022 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue $0.00
YoY Change
Gross Profit $0.00
YoY Change
Gross Profit Margin
Selling, General & Admin $436.7K $4.153M $24.06K
YoY Change 1715.17% 5458.68% 67.67%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $436.7K $4.153M $24.06K
YoY Change 1715.15% 5458.83% 67.67%
Operating Profit -$436.7K -$4.153M -$24.06K
YoY Change 1715.15% 5458.82% 67.67%
Interest Expense $63.85K -$341.0K $400.00
YoY Change 15862.75%
% of Operating Profit
Other Income/Expense, Net -$143.7K -$6.100K $0.00
YoY Change
Pretax Income -$580.5K -$4.299M -$24.06K
YoY Change 2312.55% 5655.03% 67.67%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$580.5K -$4.299M -$24.06K
YoY Change 2312.55% 5655.03% 67.67%
Net Earnings / Revenue
Basic Earnings Per Share $0.00 -$0.18 -$0.01
Diluted Earnings Per Share $0.00 -$0.18 $0.00
COMMON SHARES
Basic Shares Outstanding 210.4M shares 24.18M shares 20.05M shares
Diluted Shares Outstanding 210.4M shares 24.18M shares 20.05M shares

Balance Sheet

Concept 2023 Q4 2023 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $17.71K $431.4K
YoY Change
Cash & Equivalents $17.71K
Short-Term Investments
Other Short-Term Assets $24.47K
YoY Change
Inventory
Prepaid Expenses $24.47K
Receivables $0.00
Other Receivables
Total Short-Term Assets $42.19K $431.4K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $100.0K
YoY Change
Total Long-Term Assets $100.0K $100.0K $0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets $42.19K $431.4K
Total Long-Term Assets $100.0K $100.0K $0.00
Total Assets $142.2K $531.4K
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $477.8K $354.8K
YoY Change
Accrued Expenses $336.1K $92.15K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $813.9K $446.9K $177.8K
YoY Change 357.86% 66.05%
LONG-TERM LIABILITIES
Long-Term Debt $3.679M $3.353M $0.00
YoY Change
Other Long-Term Liabilities $1.499M $1.352M
YoY Change
Total Long-Term Liabilities $5.178M $4.705M $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $813.9K $446.9K $177.8K
Total Long-Term Liabilities $5.178M $4.705M $0.00
Total Liabilities $5.992M $5.152M $177.8K
YoY Change 3270.88% 66.05%
SHAREHOLDERS EQUITY
Retained Earnings -$29.63M -$7.431M
YoY Change 298.77% 1.02%
Common Stock $213.2K $20.05K
YoY Change 963.04% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$5.850M -$4.621M -$177.8K
YoY Change
Total Liabilities & Shareholders Equity $142.2K $531.4K
YoY Change

Cashflow Statement

Concept 2023 Q4 2023 2022 Q4
OPERATING ACTIVITIES
Net Income -$580.5K -$4.299M -$24.06K
YoY Change 2312.55% 5655.03% 67.67%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$300.2K -$147.6K $0.00
YoY Change -100.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 201.2K 361.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -300.2K -147.6K 0.000
Cash From Investing Activities 0.000
Cash From Financing Activities 201.2K 361.0K 0.000
Net Change In Cash -99.01K 213.4K 0.000
YoY Change -100.0%
FREE CASH FLOW
Cash From Operating Activities -$300.2K -$147.6K $0.00
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Revenues
Revenues
usd
CY2022Q4 us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
us-gaap Revenues
Revenues
usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--01-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Central Index Key
EntityCentralIndexKey
0001263364
CY2023Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
usd
CY2022Q4 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
usd
CY2022Q4 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
usd
CY2023Q4 COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
usd
CY2022Q4 COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
usd
COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
usd
COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
usd
COPR Recapitalization
Recapitalization
usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
usd
COPR Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
usd
us-gaap Net Income Loss
NetIncomeLoss
-1742990 usd
CY2023Q4 COPR Bond Liabilities Maturities In Year Two
BondLiabilitiesMaturitiesInYearTwo
usd
CY2023Q4 COPR Bond Liabilities Maturities In Year Three
BondLiabilitiesMaturitiesInYearThree
usd
CY2023Q4 COPR Bond Liabilities Maturities Thereafter
BondLiabilitiesMaturitiesThereafter
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q1 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
usd
CY2023Q4 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2023Q1 COPR Deferred Tax Assets Timing Differences
DeferredTaxAssetsTimingDifferences
usd
CY2023Q1 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
usd
CY2023Q4 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
CY2023Q1 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-10-31
dei Document Transition Report
DocumentTransitionReport
false
dei Entity Registrant Name
EntityRegistrantName
IDAHO COPPER CORPORATION
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity File Number
EntityFileNumber
333-108715
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-0221494
dei Entity Address Address Line1
EntityAddressAddressLine1
800 W. Main Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1460
dei Entity Address City Or Town
EntityAddressCityOrTown
Boise
dei Entity Address State Or Province
EntityAddressStateOrProvince
ID
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
83702
dei City Area Code
CityAreaCode
(208)
dei Local Phone Number
LocalPhoneNumber
274-9220
dei Security12b Title
Security12bTitle
Common
dei Trading Symbol
TradingSymbol
COPR
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
214647731 shares
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17714 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
431374 usd
CY2023Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
24472 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
42186 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
431374 usd
CY2023Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2023Q1 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
100000 usd
CY2023Q4 us-gaap Assets
Assets
142186 usd
CY2023Q1 us-gaap Assets
Assets
531374 usd
CY2023Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
477791 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
354763 usd
CY2023Q4 us-gaap Interest Payable Current
InterestPayableCurrent
42347 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
8817 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
813890 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
446913 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
3135000 usd
CY2023Q1 us-gaap Long Term Transition Bond
LongTermTransitionBond
3135000 usd
CY2023Q4 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
544116 usd
CY2023Q1 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
218429 usd
CY2023Q4 COPR Interest Payable Non Current
InterestPayableNonCurrent
1499078 usd
CY2023Q1 COPR Interest Payable Non Current
InterestPayableNonCurrent
1351609 usd
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
5178194 usd
CY2023Q1 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
4705038 usd
CY2023Q4 us-gaap Liabilities
Liabilities
5992084 usd
CY2023Q1 us-gaap Liabilities
Liabilities
5151951 usd
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
213181524 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
213181524 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
208457823 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
208457823 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
213182 usd
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
208458 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23568169 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
23059223 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-29631249 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-27888258 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5849898 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
142186 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
531374 usd
CY2023Q4 us-gaap Professional Fees
ProfessionalFees
100821 usd
CY2022Q4 us-gaap Professional Fees
ProfessionalFees
117344 usd
us-gaap Professional Fees
ProfessionalFees
357622 usd
us-gaap Professional Fees
ProfessionalFees
234900 usd
CY2023Q4 COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
282500 usd
CY2022Q4 COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
104771 usd
COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
639500 usd
COPR Payroll And Related Expenses
PayrollAndRelatedExpenses
522040 usd
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
10500 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
31500 usd
us-gaap Operating Lease Expense
OperatingLeaseExpense
30000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
140741 usd
CY2023Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
42905 usd
CY2022Q4 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
10070 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
67458 usd
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
11955 usd
CY2023Q4 us-gaap Operating Expenses
OperatingExpenses
436726 usd
CY2022Q4 us-gaap Operating Expenses
OperatingExpenses
232184 usd
us-gaap Operating Expenses
OperatingExpenses
1236821 usd
us-gaap Operating Expenses
OperatingExpenses
798895 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-436726 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-232184 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-1236821 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-798895 usd
CY2023Q4 COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
68566 usd
COPR Amortization Of Debt Instrument Convertible Beneficial Conversion Feature
AmortizationOfDebtInstrumentConvertibleBeneficialConversionFeature
203812 usd
CY2023Q4 COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
11316 usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
22633 usd
COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
144087 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200458 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
63851 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
400 usd
us-gaap Interest Expense
InterestExpense
279725 usd
us-gaap Interest Expense
InterestExpense
195740 usd
CY2023Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-143733 usd
CY2022Q4 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-401 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-506170 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
148806 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-580459 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-232584 usd
us-gaap Net Income Loss
NetIncomeLoss
-1742990 usd
us-gaap Net Income Loss
NetIncomeLoss
-650089 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
210365353 shares
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210365353 shares
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20054000 shares
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20054000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
210175251 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
210175251 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
20054000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
20054000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-8294773 usd
CY2022Q2 COPR Stock Issued During Period Value Of Recapitalization
StockIssuedDuringPeriodValueOfRecapitalization
4519207 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-223602 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-3999167 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-193903 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
-4193070 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-232584 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-4619558 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
-4620577 usd
CY2023Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
140739 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-575001 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-5054839 usd
CY2023Q3 COPR Stock Issued During Period Value Warrants Issued
StockIssuedDuringPeriodValueWarrantsIssued
103846 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-587532 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5538525 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
-5538525 usd
CY2023Q4 COPR Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
269085 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-580459 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5849898 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-5849898 usd
us-gaap Net Income Loss
NetIncomeLoss
-1742990 usd
us-gaap Net Income Loss
NetIncomeLoss
-650089 usd
us-gaap Share Based Compensation
ShareBasedCompensation
140741 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
203812 usd
COPR Amortization Of Debt Discount
AmortizationOfDebtDiscount
22633 usd
us-gaap Gain Loss On Sale Of Property
GainLossOnSaleOfProperty
200458 usd
COPR Gain On Liabilities Written Off
GainOnLiabilitiesWrittenOff
144087 usd
COPR Recapitalization
Recapitalization
139975 usd
us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
82942 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
24472 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
123030 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-56132 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
481386 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
527427 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-180999 usd
us-gaap Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
-303574 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-614860 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-442683 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
201200 usd
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
201200 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-413660 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-192683 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
431374 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217948 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
17714 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
25265 usd
COPR Stock Issued During Conversion Of Liabilities To Common Stock
StockIssuedDuringConversionOfLiabilitiesToCommonStock
269085 usd
us-gaap Nature Of Operations
NatureOfOperations
<p id="xdx_802_eus-gaap--NatureOfOperations_zzTIgSyjBbqh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_828_zcl2vle6Qj02">NATURE OF OPERATIONS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements include the financial statements of Idaho Copper Corporation (formerly known as Joway Health Industries Group Inc.) (referred to herein as “Idaho Copper”). Idaho Copper is hereinafter referred to as the “Company,” “we” and “us.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 3, 2022, the Company consummated the transactions contemplated by the Stock Purchase Agreement dated as of January 31, 2022 (the “Purchase Agreement”), by and among the Company, Crystal Globe Limited, a company incorporated under the laws of British Virgin Islands (the “Seller”), and JHP Holdings, Inc., a Nevada corporation (the “Buyer”), pursuant to which the Buyer purchased <span id="xdx_900_eus-gaap--StockRepurchasedAndRetiredDuringPeriodShares_c20220201__20220203__us-gaap--TypeOfArrangementAxis__custom--PurchaseAgreementMember_zMmyskv6Di9g" title="Buyer purchased common stock shares">16,644,820</span> shares of common stock of the Company from the Seller.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 23, 2023, the Company entered into and consummated the transactions contemplated by a share exchange agreement (the “Share Exchange Agreement”) by and among the Company, International CuMo Mining Corporation, an Idaho corporation (“ICUMO”), and all of the shareholders of ICUMO (collectively, the “ICUMO Shareholders”). Pursuant to the terms of the Share Exchange Agreement (the “RTO”), the ICUMO Shareholders transferred all the issued and outstanding shares of common stock of ICUMO to the Company in exchange for <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20230122__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zaDcM4nkccqh" title="Number of shares issued">182,240,000</span> shares of the Company’s common stock, par value $<span id="xdx_90C_eus-gaap--EmployeeStockOwnershipPlanESOPWeightedAveragePurchasePriceOfSharesPurchased_c20230122__20230123__us-gaap--TypeOfArrangementAxis__custom--ShareExchangeAgreementMember_zOZK3iz8DJ52" title="Common stock, par value">0.001</span> per share. As a result of this share exchange (the “Exchange”), ICUMO became a wholly owned subsidiary of the Company. See Note 7. For financial reporting purposes, the acquisition of ICUMO and the change of control in connection with the acquisition represented a “reverse merger” and ICUMO is deemed to be the accounting acquirer in the transaction. ICUMO is the acquirer for financial reporting purposes, and the Company is the acquired company. Consequently, the assets and liabilities and the operations that are reflected in the historical financial statements prior to the acquisition are those of ICUMO.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company continues to be a “smaller reporting company,” as defined under the Exchange Act of 1934, as amended (the “Exchange Act”) following the Exchange, however, as a result of the Exchange, the Company has ceased to be a “shell company” (as such term is defined in Rule 12b-2 under the Exchange Act).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ICUMO Background</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ICUMO is an exploration and development company with mineral right interests in the United States of America. ICUMO was originally incorporated under the laws of Nevada in 2005, as Mosquito Mining Corp. In 2013, the Company was moved to Idaho and the name changed to Idaho CuMo Mining Corporation. In early February 2023 the name was changed to Idaho Copper Corporation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nature of Operations</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of exploring its mineral rights interests in the United States and at the date of these condensed consolidated financial statements, has not yet determined whether any of its mineral properties contain economically recoverable mineral reserves. Accordingly, the carrying amount of mineral right interests represents cumulative expenditures incurred to date and does not necessarily reflect present or future values. The recovery of these costs is dependent upon the discovery of economically recoverable mineral reserves and the ability of the Company to obtain the necessary financing to complete their exploration and development and to resolve any environmental, regulatory, or other constraints. Uncertainty also exists with respect to the recoverability of the carrying value of certain mineral rights interests. The ability of the Company to realize its investment in resource properties is contingent upon the resolution of the uncertainties and confirmation of the Company’s title to the mineral properties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
17714 usd
CY2023Q4 COPR Working Capital
WorkingCapital
771704 usd
CY2023Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
357709 usd
CY2023Q1 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_846_eus-gaap--UseOfEstimates_zOMiHzQD4YBc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zosm1EExpsh1">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of consolidated financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4 us-gaap Cash Fdic Insured Amount
CashFDICInsuredAmount
250000 usd
CY2023Q4 us-gaap Cash
Cash
0 usd
CY2022Q4 us-gaap Cash
Cash
0 usd
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.05 pure
CY2023Q4 COPR Unproven Mineral Right Interests
UnprovenMineralRightInterests
0 usd
CY2023Q1 COPR Unproven Mineral Right Interests
UnprovenMineralRightInterests
0 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
3135000 usd
CY2023Q4 COPR Bond Liabilities Maturities In Remainder Of Fiscal Year
BondLiabilitiesMaturitiesInRemainderOfFiscalYear
1510000 usd
CY2023Q4 COPR Bond Liabilities Maturities In Next Twelve Months
BondLiabilitiesMaturitiesInNextTwelveMonths
536000 usd
CY2023Q4 COPR Bond Liabilities Maturities In Year Four
BondLiabilitiesMaturitiesInYearFour
1089000 usd
CY2023Q4 us-gaap Long Term Transition Bond
LongTermTransitionBond
3135000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
66993 usd
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
79583 usd
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
24254000 shares
CY2023Q1 us-gaap Share Price
SharePrice
0.125
CY2023Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Expiration Date
ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate
2027-12-31
us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-288919 usd
CY2023 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-136519 usd
us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-68790 usd
CY2023 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-32504 usd
us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
357709 usd
CY2023 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
169023 usd
CY2023Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
357709 usd
CY2023Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
357709 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
357709 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd
CY2023Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
357709 usd
CY2023Q1 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
0 usd

Files In Submission

Name View Source Status
0001493152-23-045617-index-headers.html Edgar Link pending
0001493152-23-045617-index.html Edgar Link pending
0001493152-23-045617.txt Edgar Link pending
0001493152-23-045617-xbrl.zip Edgar Link pending
copr-20231031.xsd Edgar Link pending
copr-20231031_cal.xml Edgar Link unprocessable
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
logo_01.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
copr-20231031_pre.xml Edgar Link unprocessable
copr-20231031_def.xml Edgar Link unprocessable
copr-20231031_lab.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed